ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESI....FIRO..CY..TRBGCZEEHUPLSK....................................JBDM Ver 0.1.67 (18 Oct 2017) - 2999001/0The file contains technical information submitted after the application was filed and not included in this specification3260117CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120191127W173deBibliographieenBibliographyfrBibliographieEP17185704.8200409102018062720180921enenen502219 P20030912US2019112720194820171227201752201904172019162019022720191127201948A61K 31/135 20060101AFI20171012BHEP A61K 9/28 20060101ALI20171012BHEP A61K 9/20 20060101ALI20171012BHEP A61P 5/18 20060101ALI20171012BHEP deSCHNELLAUFLÖSUNGSFORMULIERUNG ENTHALTEND CINACALCET HCLenRAPID DISSOLUTION FORMULATION COMPRISING CINACALCET HCLfrFORMULATION À DISSOLUTION RAPIDE DE CINACALCET HCLUS-B1- 6 211 244GOODMAN WILLIAM G ET AL: "The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism.", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY : JASN. APR 2002, vol. 13, no. 4, April 2002 (2002-04), pages 1017-1024, XP002313387, ISSN: 1046-6673ANONYMOUS: "Amgen submitted new drug application for Cinacalcet HCI", AMGEN NEWS RELEASE , 8 September 2003 (2003-09-08), XP002313388, Retrieved from the Internet: URL:http://www.amgen.com/news/news03/press Release030908a.pdf [retrieved on 2005-01-12]ANONYMOUS: "FDA Approves First in a New Class of Drugs to Treat Hyperparathyroidism Associated With Renal Failure and in Patients With Parathyroid Cancer", FDA TALK PAPER , 8 March 2004 (2004-03-08), XP002313389, Retrieved from the Internet: URL:http://www.fda.gov/bbs/topics/ANSWERS/ 2004/ANS01282.html [retrieved on 2005-01-11]ANONYMOUS: "Sensipar (cinacalcet HCI) Tablets", INTERNET ARTICLE , 12 August 2004 (2004-08-12), XP002313390, Retrieved from the Internet: URL:www.rxlist.com/cgi/generic3/sensipar.h tm [retrieved on 2005-01-10]NEMETH EDWARD F ET AL: "Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl.", THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. FEB 2004, vol. 308, no. 2, February 2004 (2004-02), pages 627-635, XP009042339, ISSN: 0022-3565"Cinacalcet: AMG 073, Calcimimetics--Amgen/NPS Pharmaceuticals, KRN 1493, NPS 1493.", DRUGS IN R&D. 2003, vol. 4, no. 6, 2003, pages 349-351, XP009042342, ISSN: 1174-5886ANONYMOUS: "NPS-Drug Development: Product Develpment Pipeline", INTERNET ARTICLE , 8 September 2003 (2003-09-08), XP002313391, Retrieved from the Internet: URL:www.npsp.com/drug_development/pipeline .php [retrieved on 2005-01-12]14163366.928210672014040310014567.123164422010111204781429.816631822004091018175495.333953382018060118175497.933953392018060118175499.533953402018060119164145.520190320ÁLVAREZ, Francisco J.817 Paseo De LeonNewbury Park, CA California 91320USJU, Tzuchi R.1438 N. Butler CourtVernon Hills, IL Illinois 60061USLIN, Hung-Ren H.5086 Durant CourtOak Park, CA California 91377USLAWRENCE, Glen CaryOne Amgen Center DriveThousand Oaks, CA California 91320-1799USAmgen Inc.101179610E1043990(T)EPD1One Amgen Center DriveThousand Oaks, CA 91320-1799USEIP101401446EIP Europe LLP Fairfax House 15 Fulwood PlaceLondon WC1V 6HUGBATBEBGCHCYCZDEDKEEESFIFRGBGRHUIEITLILUMCNLPLPTROSESISKTR